Mortalin is down-regulated in neurons of patients with neurodegenerative diseases and levels of Mortalin expression are correlated with neuronal fate in animal models of Alzheimer's disease or cerebral ischemia. This evidence concerns the gene HSPA9 and early-onset autosomal dominant Alzheimer disease.